胸大肌肌内乳房假体置入在二次乳房固定隆乳术中的应用
本文回顾性分析了2005至2022年间由同一术者完成的319例二次隆乳或乳房固定隆乳术,其中196例采用胸大肌肌内腔隙技术。平均随访21.5个月,肌内腔隙病例未出现包膜挛缩或动画畸形。作者认为该技术是二次隆乳安全有价值的方法,证据等级为治疗性IV级。
要点
- 胸大肌肌内腔隙在肌束间分离,几乎不出血。
- 196例肌内腔隙病例随访期间无包膜挛缩或动画畸形。
- 作者认为该技术是二次隆乳安全有价值的方法。
核心结论
- 胸大肌肌内腔隙技术是二次隆乳安全且有价值的技术。
研究设计与样本
- 回顾性病历审查,纳入2005至2022年由同一术者(R.M.G.)完成的二次隆乳或乳房固定隆乳术患者,共319例,其中196例采用胸大肌肌内腔隙技术。
- 证据等级:治疗性,IV级。
主要发现
- 患者平均随访21.5个月。
- 319例中196例采用胸大肌肌内腔隙技术。
- 肌内腔隙病例在随访期间未出现包膜挛缩或动画畸形。
临床怎么用
- 作者认为胸大肌肌内腔隙技术是二次隆乳安全且有价值的技术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Breast augmentation with implants is one of the most performed aesthetic surgical procedures performed worldwide. The authors describe a new option for breast implant secondary procedures, the intra-pectoralis major pocket, as a feasible and reproducible surgical technique. METHODS: A retrospective chart review was conducted on all patients who underwent a revision augmentation or mastopexy augmentation procedure between 2005 and 2022 performed by the senior author (R.M.G.). The intramuscular pocket is dissected between the pectoralis muscle fascicles where it is almost not bleeding. RESULTS: Patients were followed up for an average of 21.5 months. A total of 319 patients underwent revisionary breast augmentation/mastopexy performed by the senior author (R.M.G.). Indications for reoperation were based both on specific patient dissatisfaction with their original surgery and the surgeon's physical examination and assessment. In 196 cases, the authors performed the intramuscular pocket technique. None of the intramuscular pockets had capsular contracture or animation deformity in the follow-up period. CONCLUSION: The intramuscular pocket technique is a valuable and safe technique for secondary breast augmentation. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
引用
- Graf RM, Ono MCC, de Paula DR, et al. Intramuscular Breast Augmentation in Secondary Mastopexy Augmentation. Plast Reconstr Surg. 2024. PMID: 38857439. doi:10.1097/PRS.0000000000011577
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。